動物用ワクチン市場：動物タイプ、技術、投与経路、流通チャネル別-2025年～2030年の世界予測

動物用ワクチン市場は、2023年に98億2,000万米ドルと評価され、2024年には104億米ドルに達すると予測され、CAGR 6.43％で成長し、2030年には151億9,000万米ドルに達すると予測されています。

動物用ワクチン市場は、家畜およびコンパニオンアニマル全体の疾病を予防し、健康を増進し、生産性を向上させるために、動物用に調整されたワクチンの開発と生産を包含します。これらのワクチンは、人獣共通感染症の発生を予防し、動物の死亡率を低下させ、農業セクターにおける経済的損失を最小限に抑えるために不可欠です。その用途は牛や家禽などの家畜からペットまで多岐にわたる。この多様な市場は、主に動物ヘルスケア支出の増加、家畜人口の増加、動物由来の食品需要の増加といった要因によって牽引されています。さらに、ペットの飼育率の増加がコンパニオンアニマル・ワクチンの需要を煽っています。主な成長要因としては、新規ワクチンの開発を後押ししているバイオテクノロジーの発展や、動物の健康を支援する政府の取り組みなどが挙げられます。畜産が急増しているアジア太平洋やアフリカのような、調査が不十分な地域でのサービス拡大には潜在的なビジネスチャンスがあります。現地の動物病院と提携し、ニーズに合わせたワクチン接種戦略を模索することで、市場への浸透をさらに高めることができます。しかし、ワクチンの保管や輸送にかかる高いコスト、規制上のハードル、家畜所有者のワクチンへのためらいといった課題が成長を制限しています。さらに、特に開発途上地域では、動物の健康習慣に関する認識不足が広がっています。技術革新という点では、幅広いスペクトラムを有し、免疫力が長期間持続するワクチンの開発は、ゲームチェンジをもたらす可能性があります。DNAワクチンや組み換えワクチンのようなバイオテクノロジーの革新は、有利な研究開発分野です。有望な成長軌道にもかかわらず、市場競争は中程度の激しさを示しており、注目すべき企業は研究開発や合併・買収に多額の投資を行い、製品ラインや市場拡大を図っています。持続的成長のためには、戦略的な教育イニシアティブによる制限への対応と流通網の強化が極めて重要です。企業は、潜在的な落とし穴を避けるために規制遵守に焦点を当て、動物の健康とワクチン接種の利点に関する認識を向上させる取り組みを支援すべきです。

市場力学：急速に進化する動物用ワクチン市場の主要市場インサイトを公開

動物用ワクチン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • コンパニオンアニマルおよび家畜の飼育数の増加
  • 動物の慢性疾患や偶発的傷害の発生率の増加
  • 獣医動物の予防接種に対する政府の取り組み
• 市場抑制要因
  • ワクチンの開発、保管、取り扱いに伴う高コスト
• 市場機会
  • 弱毒生ワクチンからDNAワクチンへの移行
  • 新規動物用ワクチン開発のための投資と研究開発の増加
• 市場の課題
  • 厳しい規制遵守に伴う懸念

ポーターのファイブフォース：動物用ワクチン市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、動物用ワクチン市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：動物用ワクチン市場における外部からの影響の把握

外部マクロ環境要因は、動物用ワクチン市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析動物用ワクチン市場における競合情勢の把握

動物用ワクチン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス動物用ワクチン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、動物用ワクチン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨動物用ワクチン市場における成功への道筋を描く

動物用ワクチン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ペットや家畜の飼育数の増加
    • 動物の慢性疾患や事故による傷害の発生率の上昇
    • 獣医動物の予防接種に関する政府の取り組み
  • 抑制要因
    • ワクチンの開発、保管、取り扱いに伴う高コスト
  • 機会
    • 生弱毒化ワクチンからDNAワクチンへの移行
    • 新規開発への投資と研究開発の増加動物用ワクチン
  • 課題
    • 厳格な規制遵守に伴う懸念
• 市場セグメンテーション分析
  • 動物の種類：家畜の病気予防のためのワクチンの使用増加
  • 技術：狂犬病、インフルエンザ、レプトスピラ症などの対象疾患の負担を軽減するために不活化センサーの使用を増やす
  • 投与経路：使いやすく非侵襲的な性質のため、鼻腔投与が好まれる傾向が高まっています。
  • 流通チャネル：獣医病院や診療所でのワクチンの入手しやすさの向上
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 動物用ワクチン市場：動物タイプ別

• 養殖業
• コンパニオンアニマル
• 家畜
  • 牛
  • 豚肉
  • 家禽
  • 小型反芻動物

第7章 動物用ワクチン市場：技術別

• 不活化ワクチン
• 生弱毒化ワクチン
• 組み換えワクチン
• トキソイドワクチン

第8章 動物用ワクチン市場：投与経路別

• 静脈内
• 鼻腔
• 経口

第9章 動物用ワクチン市場：流通チャネル別

• 病院・クリニック
• 小売薬局

第10章 南北アメリカの動物用ワクチン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋の動物用ワクチン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの動物用ワクチン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • メルクアニマルヘルス、3種混合の豚ワクチンを発売
  • IIL、700カロールインドルピーを投じてインドのハイデラバードに新たな動物ワクチンユニットを設立
  • メルクアニマルヘルスがベンクを買収
• 戦略分析と提言

企業一覧

• Addison Biological Laboratory Inc.
• Aptimmune Biologics, Inc
• Bimeda Inc.
• Biokema SA
• Boehringer Ingelheim International GmbH
• Brilliant Bio Pharma Private Limited
• Ceva Sante Animale
• China Animal Husbandry Industry Co., Ltd
• Covetrus, Inc.
• Elanco Animal Health Incorporated
• Endovac Animal Health.
• Hester Biosciences Limited
• HIPRA, S.A
• Indian Immunologicals Ltd.
• Kemin Industries, Inc.
• Kyoritsuseiyaku Corporation
• Laboratoire LCV
• Meiji Holdings Co., Ltd.
• Merck & Co., Inc
• Neogen Corporation
• Norbrook Laboratories Limited
• Phibro Animal Health Corporation
• Saiba Animal Health AG
• Sumitomo Pharma Animal Health Co., Ltd.
• Torigen Pharmaceuticals Inc.
• Vaxxinova International BV
• Virbac SA
• YEBIO BIOENGINEERING CO., LTD OF QINGDAO
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. VETERINARY VACCINES MARKET RESEARCH PROCESS
• FIGURE 2. VETERINARY VACCINES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VETERINARY VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. VETERINARY VACCINES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. VETERINARY VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VETERINARY VACCINES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VETERINARY VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VETERINARY VACCINES MARKET DYNAMICS
• TABLE 7. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VETERINARY VACCINES MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VETERINARY VACCINES MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VETERINARY VACCINES MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VETERINARY VACCINES MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VETERINARY VACCINES MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VETERINARY VACCINES MARKET SIZE, BY SMALL RUMINANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VETERINARY VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL VETERINARY VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL VETERINARY VACCINES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL VETERINARY VACCINES MARKET SIZE, BY NASAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL VETERINARY VACCINES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL VETERINARY VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 44. CANADA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 46. CANADA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. CANADA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 48. CANADA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 71. CHINA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 72. CHINA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 73. CHINA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. CHINA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 75. CHINA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 76. INDIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 77. INDIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 78. INDIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. INDIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 80. INDIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 162. ITALY VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 163. ITALY VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 164. ITALY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 165. ITALY VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 166. ITALY VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 182. POLAND VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 183. POLAND VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 184. POLAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 185. POLAND VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 186. POLAND VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 187. QATAR VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 188. QATAR VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 189. QATAR VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 190. QATAR VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 191. QATAR VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 237. VETERINARY VACCINES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 238. VETERINARY VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

The Veterinary Vaccines Market was valued at USD 9.82 billion in 2023, expected to reach USD 10.40 billion in 2024, and is projected to grow at a CAGR of 6.43%, to USD 15.19 billion by 2030.

The veterinary vaccines market encompasses the development and production of vaccines tailored for animals to prevent diseases, enhance health, and improve productivity across livestock and companion animals. These vaccines are essential for preventing outbreaks of zoonotic diseases, reducing animal mortality, and minimizing economic losses in the agricultural sector. Their application covers livestock, such as cattle and poultry, and extends to pets. This diverse market is primarily driven by factors like rising animal healthcare expenditure, an increase in livestock population, and growing demand for animal-derived food products. Additionally, the increased pet adoption rates fuel the demand for companion animal vaccines. Key growth influencers include advancements in biotechnology, which have propelled the development of novel vaccines, and governmental initiatives supporting animal health. Potential opportunities lie in expanding services in under-researched regions like Asia-Pacific and Africa, where livestock farming is burgeoning. Exploring partnerships with local veterinary clinics for tailored vaccination strategies can further enhance market penetration. However, challenges such as high costs of vaccine storage and transportation, regulatory hurdles, and vaccine hesitancy among livestock owners limit growth. Additionally, there's a widespread lack of awareness regarding animal health practices, particularly in developing regions. In terms of innovation, developing vaccines with broad-spectrum capabilities and those offering long-lasting immunity can be game-changing. Biotechnology innovations such as DNA and recombinant vaccines present lucrative R&D areas. Despite the promising growth trajectory, the market shows moderate competitive intensity with notable players investing heavily in R&D and mergers/acquisitions to augment product lines and market reach. Addressing limitations via strategic educational initiatives and enhancing distribution networks are pivotal for sustained growth. Businesses should focus on regulatory compliance to avoid potential pitfalls and support efforts to improve awareness about animal health and vaccination benefits.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Vaccines Market

The Veterinary Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing number of companion animal and livestock ownership
  • Rising incidence of chronic diseases and accidental injuries in animals
  • Government initiatives for immunization of veterinary animals
• Market Restraints
  • High cost associated with development, storage, and handling of vaccines
• Market Opportunities
  • Shift from live attenuated vaccines to DNA vaccines
  • Rising investments and R&D for development of novel veterinary vaccines
• Market Challenges
  • Concerns associated with stringent regulatory compliance

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Vaccines Market

A detailed market share analysis in the Veterinary Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Vaccines Market

A strategic analysis of the Veterinary Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Vaccines Market, highlighting leading vendors and their innovative profiles. These include Addison Biological Laboratory Inc., Aptimmune Biologics, Inc, Bimeda Inc., Biokema SA, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, Ceva Sante Animale, China Animal Husbandry Industry Co., Ltd, Covetrus, Inc., Elanco Animal Health Incorporated, Endovac Animal Health., Hester Biosciences Limited, HIPRA, S.A, Indian Immunologicals Ltd., Kemin Industries, Inc., Kyoritsuseiyaku Corporation, Laboratoire LCV, Meiji Holdings Co., Ltd., Merck & Co., Inc, Neogen Corporation, Norbrook Laboratories Limited, Phibro Animal Health Corporation, Saiba Animal Health AG, Sumitomo Pharma Animal Health Co., Ltd., Torigen Pharmaceuticals Inc., Vaxxinova International BV, Virbac SA, YEBIO BIOENGINEERING CO., LTD OF QINGDAO, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Animal Type, market is studied across Aquaculture, Companion Animals, and Livestock. The Livestock is further studied across Bovine, Porcine, Poultry, and Small Ruminants.
• Based on Technology, market is studied across Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, and Toxoid Vaccines.
• Based on Route of Administration, market is studied across Intravenous, Nasal, and Oral.
• Based on Distribution Channel, market is studied across Hospitals & Clinics and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing number of companion animal and livestock ownership
    • 5.1.1.2. Rising incidence of chronic diseases and accidental injuries in animals
    • 5.1.1.3. Government initiatives for immunization of veterinary animals
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with development, storage, and handling of vaccines
  • 5.1.3. Opportunities
    • 5.1.3.1. Shift from live attenuated vaccines to DNA vaccines
    • 5.1.3.2. Rising investments and R&D for development of novel veterinary vaccines
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with stringent regulatory compliance
• 5.2. Market Segmentation Analysis
  • 5.2.1. Animal Type: Rising usage of vaccines for disease prevention in livestock animals
  • 5.2.2. Technology: Increasing use of inactivated sensors to reduce the burden of target diseases such as rabies, influenza, and leptospirosis
  • 5.2.3. Route of Administration: Growing preference for nasal administration owing to its user-friendly and non-invasive nature
  • 5.2.4. Distribution Channel: Rising accessibility of vaccines across veterinary hospitals & clinics
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Veterinary Vaccines Market, by Animal Type

• 6.1. Introduction
• 6.2. Aquaculture
• 6.3. Companion Animals
• 6.4. Livestock
  • 6.4.1. Bovine
  • 6.4.2. Porcine
  • 6.4.3. Poultry
  • 6.4.4. Small Ruminants

7. Veterinary Vaccines Market, by Technology

• 7.1. Introduction
• 7.2. Inactivated Vaccines
• 7.3. Live Attenuated Vaccines
• 7.4. Recombinant Vaccines
• 7.5. Toxoid Vaccines

8. Veterinary Vaccines Market, by Route of Administration

• 8.1. Introduction
• 8.2. Intravenous
• 8.3. Nasal
• 8.4. Oral

9. Veterinary Vaccines Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Hospitals & Clinics
• 9.3. Retail Pharmacies

10. Americas Veterinary Vaccines Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Veterinary Vaccines Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Veterinary Vaccines Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Merck Animal Health launches 3-in-one swine vaccine
  • 13.3.2. IIL to set up new animal vaccine unit in Hyderabad, India at INR 700 crore
  • 13.3.3. Merck Animal Health to Acquire Venc
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Addison Biological Laboratory Inc.
• 2. Aptimmune Biologics, Inc
• 3. Bimeda Inc.
• 4. Biokema SA
• 5. Boehringer Ingelheim International GmbH
• 6. Brilliant Bio Pharma Private Limited
• 7. Ceva Sante Animale
• 8. China Animal Husbandry Industry Co., Ltd
• 9. Covetrus, Inc.
• 10. Elanco Animal Health Incorporated
• 11. Endovac Animal Health.
• 12. Hester Biosciences Limited
• 13. HIPRA, S.A
• 14. Indian Immunologicals Ltd.
• 15. Kemin Industries, Inc.
• 16. Kyoritsuseiyaku Corporation
• 17. Laboratoire LCV
• 18. Meiji Holdings Co., Ltd.
• 19. Merck & Co., Inc
• 20. Neogen Corporation
• 21. Norbrook Laboratories Limited
• 22. Phibro Animal Health Corporation
• 23. Saiba Animal Health AG
• 24. Sumitomo Pharma Animal Health Co., Ltd.
• 25. Torigen Pharmaceuticals Inc.
• 26. Vaxxinova International BV
• 27. Virbac SA
• 28. YEBIO BIOENGINEERING CO., LTD OF QINGDAO
• 29. Zoetis Inc.